COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know
This is a recording of the webinar, COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know, that aired November 16, 2022.

Leading transplant experts share vital information to help you make informed healthcare decisions before and after transplant.
This is a recording of the webinar, COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know, that aired November 16, 2022.
Acute myeloid leukemia is a diagnosis that affects mainly older adults. Treatment options depend on the type of AML a patient has, age, prior treatment and general health. Learn the details on how recommendations for treatment are determined.
Graft-versus-host disease (GVHD) is a frequent complication after a stem cell transplant using donor cells. GVHD can affect many parts of the body including the genitals.
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
Learn how stem cell transplant recipients can best protect themselves against COVID-19, and newest treatment options available if you do get COVID-19.